Senior insider sale
CEO at BEAM THERAPEUTICS INC. — senior position signals high conviction
$2.91M
116.87K shares
What this filing means
EVANS JOHN M. plans to sell 116.87K shares of BEAM THERAPEUTICS INC. valued at approximately $2.91M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001193125-26-134643
DirectorOfficer· CEO
Since Feb 2020
116.87K
Shares to sell
$2.91M
Approx. market value
66.87K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Services Rendered
3/31/2026
66.87KTotal acquired66.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2026 | Restricted Stock Vesting Services Rendered | 66.87K | — |
| Total | 66.87K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
25K
Market value
$708.9K
1/30/2026
—Completed
Units to sell
25K
Market value
$734.6K
1/29/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
66.87K
Market value
$1.46M
4/2/2026
Total
Units
116.87K
Value
$2.91M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/30/2026 | 25K | $708.9K | — | Completed |
1/29/2026 | 25K | $734.6K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 66.87K | $1.46M | NASDAQ | Planned |
| Total | 116.87K | $2.91M | ||